Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 15/20 | 0.64 |
| ▸ | CA2 | P00918 | 15/20 | 0.64 |
| ▸ | CA9 | Q16790 | 13/20 | 0.64 |
| ▸ | CA12 | O43570 | 4/20 | 0.64 |
| ▸ | CA7 | P43166 | 4/20 | 0.64 |
| ▸ | CA14 | Q9ULX7 | 4/20 | 0.64 |
| ▸ | CA3 | P07451 | 3/20 | 0.64 |
| ▸ | CA4 | P22748 | 3/20 | 0.64 |
| ▸ | CA6 | P23280 | 3/20 | 0.64 |
| ▸ | CA5A | P35218 | 3/20 | 0.64 |
| ▸ | CA5B | Q9Y2D0 | 3/20 | 0.64 |
| ▸ | RECQL | P46063 | 2/20 | 0.61 |
| ▸ | TSHR | P16473 | 2/20 | 0.61 |
| ▸ | GLA | P06280 | 1/20 | 0.61 |
| ▸ | HPGD | P15428 | 1/20 | 0.61 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.61 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.61 |
| ▸ | BLM | P54132 | 1/20 | 0.61 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.46 |
| ▸ | USP2 | O75604 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3381868 | 1.00 | CA1 (0.64) | CA1CA2CA9CA12CA7 | |
| SCHEMBL7026427 | 1.00 | CA1 (0.64) | CA1CA2CA9CA12CA7 | |
| SCHEMBL3383864 | 1.00 | CA1 (0.64) | CA1CA2CA9CA12CA7 | |
| SCHEMBL456205 | 1.00 | CA1 (0.64) | CA1CA2CA9CA12CA7 | |
| SCHEMBL2672727 | 1.00 | CA1 (0.64) | CA1CA2CA9CA12CA7 | |
| SCHEMBL3382443 | 0.97 | CA1 (0.62) | CA1CA2CA9CA12CA7 | |
| SCHEMBL2672190 | 0.90 | — | — | |
| SCHEMBL771183 | 0.82 | CA1 (0.67) | CA1CA2CA9CA12CA7 | |
| SCHEMBL2494632 | 0.82 | CA1 (0.67) | CA1CA2CA9CA12CA7 | |
| SCHEMBL147679 | 0.82 | CA1 (0.67) | CA1CA2CA9CA12CA7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10270038-B2 | Fullerene derivative, organic solar cell using same, and preparation method therefor | LG CHEM, LTD. (KR) | 2019-04-23 | — | — | US | disclosed |
| EP-3103801-B1 | FULLERENE DERIVATIVE, ORGANIC SOLAR CELL USING SAME, AND PREPARATION METHOD THEREFOR | LG CHEMICAL LTD (KR) | 2018-07-04 | — | — | EP | disclosed |
| EP-3103801-A1 | FULLERENE DERIVATIVE, ORGANIC SOLAR CELL USING SAME, AND PREPARATION METHOD THEREFOR | LG Chem, Ltd. (KR) | 2016-12-14 | — | — | EP | disclosed |
| US-20160329499-A1 | FULLERENE DERIVATIVE, ORGANIC SOLAR CELL USING SAME, AND PREPARATION METHOD THEREFOR | LG CHEM, LTD. (KR) | 2016-11-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160329499-A1 | FULLERENE DERIVATIVE, ORGANIC SOLAR CELL USING SAME, AND PREPARATION METHOD THEREFOR | WEE2, WEE1, STOML2 | CA1 1880/4885CA2 2634/4885CA9 1746/4885 |
| US-10270038-B2 | Fullerene derivative, organic solar cell using same, and preparation method therefor | WEE2, WEE1, STOML2 | CA1 1880/4885CA2 2634/4885CA9 1746/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.